Edition:
United Kingdom

China Regenerative Medicine International Ltd (8158.HK)

8158.HK on Hong Kong Stock

0.15HKD
23 May 2018
Change (% chg)

HK$-0.00 (-0.67%)
Prev Close
HK$0.15
Open
HK$0.15
Day's High
HK$0.15
Day's Low
HK$0.14
Volume
37,750,000
Avg. Vol
23,226,690
52-wk High
HK$0.28
52-wk Low
HK$0.14

Latest Key Developments (Source: Significant Developments)

China Regenerative Medicine International Posts Q1 Loss Attributable HK$53.4 Mln
Friday, 11 May 2018 

May 11 (Reuters) - China Regenerative Medicine International Ltd <8158.HK>::Q1 LOSS ATTRIBUTABLE HK$53.4 MILLION VERSUS LOSS HK$54 MILLION.Q1 REVENUE HK$25.4 MILLION VERSUS HK$138.9 MILLION.  Full Article

China Regenerative Medicine International Posts FY Loss Attributable To Owners Of Co Of HK$158.5 Mln
Tuesday, 27 Mar 2018 

March 28 (Reuters) - China Regenerative Medicine International Ltd <8158.HK>::FY REVENUE HK$503.7, UP 41.1%.FY LOSS ATTRIBUTABLE TO OWNERS OF CO HK$158.5 MILLION VERSUS LOSS OF HK$184.5 MILLION.  Full Article

China Regenerative Medicine International Says ‍Substantial Shareholder Ups Stake In Co
Wednesday, 24 Jan 2018 

Jan 24 (Reuters) - China Regenerative Medicine International Ltd <8158.HK>::‍SUBSTANTIAL SHAREHOLDER INCREASED SHAREHOLDING BY 1.55 BILLION ORDINARY SHARES OF COMPANY​.  Full Article

China Regenerative Medicine International Entered Agreement With Shanghai Lingang Songjiang High-Tech Industry Development
Tuesday, 16 Jan 2018 

Jan 16 (Reuters) - China Regenerative Medicine International Ltd <8158.HK>::ENTERED COOPERATION FRAMEWORK AGREEMENT WITH SHANGHAI LINGANG SONGJIANG HIGH-TECH INDUSTRY DEVELOPMENT.AGREEMENT FOR DEVELOPMENT & CONSTRUCTION OF SCIENCE OASIS SITE​.  Full Article

China Regenerative Medicine International To By ‍Lung Hang Investments For HK$3.6 Bln-HK$$3.8 Bln​
Monday, 11 Dec 2017 

Dec 11 (Reuters) - China Regenerative Medicine International Ltd <8158.HK>::CO TO BY ‍LUNG HANG INVESTMENTS FROM SACRED HEART HEALTHCARE LTD PARTNERSHIP FOR HK$3.6 BILLION TO HK$3.8 BILLION​.  Full Article

China Regenerative Medicine International Says Qtrly Revenue Hk$89 Million
Friday, 8 Dec 2017 

Dec 8 (Reuters) - China Regenerative Medicine International Ltd <8158.HK>::QTRLY REVENUE HK$89 MILLION VERSUS HK$25.5 MILLION ‍​.QTRLY NET LOSS HK$63.3 MILLION VERSUS NET LOSS OF HK$61.8 MLN‍​.  Full Article

China Regenerative Medicine International Says ‍Wong Sai Hung Resigned As Vice-Chairman
Thursday, 30 Nov 2017 

Nov 30 (Reuters) - China Regenerative Medicine International Ltd <8158.HK>::WONG SAI HUNG RESIGNED AS EXECUTIVE DIRECTOR AND VICE-CHAIRMAN OF BOARD​.  Full Article

China Regenerative Medicine International says unit to sell Shaanxi Aimiya​ to third party
Wednesday, 18 Oct 2017 

Oct 18 (Reuters) - China Regenerative Medicine International Ltd <8158.HK>::Unit entered into deal to sell 100 percent stake in Shaanxi Aimiya​ to third party buyer.Estimated gain on disposal of about RMB28.6 million to be recorded in group's FY ending Dec. 31, 2017​.Unit to also sell loan to third party purchaser; consideration for SPA and loan RMB40 million​.  Full Article

China Regenerative Medicine International says Cui Zhanfeng will be appointed as Chairman
Wednesday, 28 Sep 2016 

China Regenerative Medicine International Ltd <8158.HK>: Cui zhanfeng will be appointed as chairman and non-executive director of company .Wong sai hung will be re-designated from chairman to vice-chairman.  Full Article

China Regenerative Medicine International enters into a collaboration agreement
Friday, 23 Sep 2016 

China Regenerative Medicine International Ltd <8158.HK> : Entered into a collaboration agreement with University Of Hong Kong ("HKU") and Innovation And Technology Commission of HKSAR . Estimated cost of project is approximately hk$8.8 million . Pursuant to collaboration agreement, co shall hold all intellectual property rights arouse from project in its sole name Source (http://bit.ly/2cqmyUV) Further company coverage: [8158.HK] ((Bangalore.newsroom@thomsonreuters.com;)).  Full Article

No consensus analysis data available.